Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Kedudukan dalam Saham #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Harga Saham
$7.15
Modal Pasaran
$313.60M
Perubahan (1 hari)
-2.12%
Perubahan (1 tahun)
-84.14%
Negara
DE
Perdagangan Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategori

Nisbah P/B bagi Anbio Biotechnology Class A Ordinary Shares (NNNN)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Anbio Biotechnology Class A Ordinary Shares, nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Anbio Biotechnology Class A Ordinary Shares dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
7.3533 -
US
1.8857 -
FR
- -
JP
2.1171 -
US
- -
CH